MLchartDataset catalogue

CBT-1

Term · Oncology and biomedicine · MLC-T-ONC-001509

A substance taken from plants that is being studied in the treatment of cancer. It may help drugs kill tumor cells that have become resistant to drugs. It is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist. Also called MDR modulator CBT-1.

Table 1. Record
IdentifierMLC-T-ONC-001509
FieldOncology and biomedicine
ExpansionsMDR modulator CBT-1
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-001509",
  "term": "CBT-1",
  "field": "Oncology and biomedicine",
  "definition": "A substance taken from plants that is being studied in the treatment of cancer. It may help drugs kill tumor cells that have become resistant to drugs. It is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist. Also called MDR modulator CBT-1.",
  "expansions": [
    "MDR modulator CBT-1"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/cbt-1/"
}

Record 4,350 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.